Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
Glob Health Action ; 16(1): 2161231, 2023 12 31.
Article in English | MEDLINE | ID: mdl-36621943

ABSTRACT

Due to the workload and lack of a critical mass of trained operational researchers within their ranks, health systems and programmes may not be able to dedicate sufficient time to conducting operational research (OR). Hence, they may need the technical support of operational researchers from research/academic organisations. Additionally, there is a knowledge gap regarding implementing differentiated tuberculosis (TB) care in programme settings. In this 'how we did it' paper, we share our experience of implementing a differentiated TB care model along with an inbuilt OR component in Tamil Nadu, a southern state in India. This was a health system initiative through a collaboration of the State TB cell with the Indian Council of Medical Research institutes and the World Health Organisation country office in India. The learnings are in the form of eleven tips: four broad principles (OR on priority areas and make it a health system initiative, implement simple and holistic ideas, embed OR within routine programme settings, aim for long-term engagement), four related to strategic planning (big team of investigators, joint leadership, decentralised decision-making, working in advance) and three about implementation planning (conducting pilots, smart use of e-tools and operational research publications at frequent intervals). These may act as a guide for other Indian states, high TB burden countries that want to implement differentiated care, and for operational researchers in providing technical assistance for strengthening implementation and conducting OR in health systems and programmes (TB or other health programmes). Following these tips may increase the chances of i) an enriching engagement, ii) policy/practice change, and iii) sustainable implementation.


Subject(s)
Biomedical Research , Tuberculosis , Humans , India , Tuberculosis/prevention & control , Government Programs , Organizations
2.
Lett Appl Microbiol ; 65(5): 423-430, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28901019

ABSTRACT

Mass mortalities of cobia, Rachycentron canadum, sub-adults occurred during August 2013 in cage culture in the Gulf of Mannar, Mandapam Tamil Nadu, India. The epizootic of disease was started with typical classical clinical signs followed by acute mortality. Grossly, severe haemorrhage and congestion were observed in the gastric mucosa. The abdomen was distended with peritoneal fluid. The heart revealed haemopericardium and fibrinous pericardium. Histologically, the gastric mucosa showed severe erosion and necrosis. Haemorrhagic pericarditis and an increased size of the melano macrophage centre (MMC) in the tail kidney were other histopathological changes. Vibrio sp. was isolated from the gastric lesions and heart blood swab of moribund fishes and it was found to be virulent to the cobia fingerlings. After the challenge, the same bacterium could be re-isolated from moribund fingerlings. The 16S ribosomal RNA of the isolate was amplified and blast analysis of the sequence confirmed that the pathogen was Vibrio alginolyticus. The confirmation was also correlated with its cultural, biochemical and pathomorphological changes. This is the second report and the first incidence of epizootics with severe pathological lesions in cultured cobia in India. The study throws light on the pathology of vibriosis. By practising cage farm management measures, occurrences of infection may be prevented. SIGNIFICANCE AND IMPACT OF THE STUDY: The epizootics of vibriosis caused serious economic losses to farmers. Natural blooms of the pathogen can be prevented by sea cage management measures such as, changing the inner net of the cages, changing the location of the cages to relatively clean water (about 50 m apart) from the affected site and providing shade over the cages while the water temperature rises. Supplementation of the feed with immunostimulants and mineral mixture may be practised to improve the immune response against infection. Early diagnosis and sea cage management measures may prevent occurrences of the infection.


Subject(s)
Fish Diseases/microbiology , Perciformes/microbiology , Vibrio Infections/veterinary , Vibrio alginolyticus/isolation & purification , Animals , India , Kidney/microbiology , Perciformes/growth & development , Vibrio Infections/microbiology , Vibrio alginolyticus/genetics , Vibrio alginolyticus/pathogenicity , Virulence
3.
Chem Biol Interact ; 180(1): 10-9, 2009 Jun 15.
Article in English | MEDLINE | ID: mdl-19428341

ABSTRACT

In the present study, the efficacy of green tea catechins (GTC from the plant Camellia sinensis), with epigallocatechin gallate (EGCG), as the major component, was studied in relation to hepatic oxidative abnormalities in atherosclerotic rats. When male albino Wistar rats were fed an atherogenic diet for 30 days and then treated with saline for 7 or 15 days, there was a significant decline in hepatic mean activities of antioxidant enzymes (catalase, superoxide dismutase, glutathione peroxidase and glutathione-S-transferase), and non-enzymatic antioxidants (reduced glutathione, vitamins C and E) while there was a significant elevation in the mean level of hepatic malondialdehyde (MDA), in comparison to the values noted in control rats fed a normal diet. In addition, a concomitant increase in the activities of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) was noted, when compared to the values in control rats. Following intraperitoneal administration of GTC (100mg/kg) for 7 or 15 days to rats fed the atherogenic diet, significantly higher mean activities of enzymatic and non-enzymatic antioxidants and lower mean levels of MDA in hepatic tissue and lower mean activities of AST, ALT, ALP and LDH in serum were observed, compared to the values in the rats fed the atherogenic diet and treated with saline. Histopathological studies were performed to provide direct evidence of the atherogenic diet-induced hepatic changes and of the hepatoprotective effect of GTC. These results suggest that EGCG as a major component of green tea catechins may protect against the hepatic abnormalities occurring in Wistar rats fed an atherogenic diet.


Subject(s)
Catechin/pharmacology , Diet, Atherogenic , Lipid Peroxidation/drug effects , Liver/enzymology , Liver/injuries , Plant Extracts/pharmacology , Plant Leaves/chemistry , Animals , Antioxidants/metabolism , Camellia sinensis , Catalase/genetics , Catalase/metabolism , Catechin/administration & dosage , Male , Oxidative Stress , Plant Extracts/administration & dosage , RNA, Messenger/metabolism , Rats , Rats, Wistar
4.
Curr Eye Res ; 34(4): 264-73, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19373574

ABSTRACT

PURPOSE: To evaluate the efficacy of Pleurotus ostreatus extract in preventing selenite-induced cataractogenesis. METHODS: In vitro, enucleated rat lenses, divided into one control and three experimental groups (selenite only, simultaneous selenite and extract, initial extract and subsequent selenite), underwent morphological and biochemical evaluation. The anti-cataractogenic effect was also evaluated in vivo. RESULTS: In vitro, simultaneous incubation of extract with selenite-challenged lenses caused a decrease in lens opacification by maintaining antioxidant components at near normal levels. In vivo, P.ostreatus (300 mg/kg body weight) prevented cataract in 75% of rats. CONCLUSION: Extract of P. ostreatus prevents experimental selenite-induced cataractogenesis.


Subject(s)
Cataract/chemically induced , Cataract/prevention & control , Plant Extracts/pharmacology , Pleurotus/chemistry , Sodium Selenite , Animals , Antioxidants/metabolism , Cataract/pathology , Dose-Response Relationship, Drug , In Vitro Techniques , Lens, Crystalline/drug effects , Lens, Crystalline/enzymology , Lens, Crystalline/metabolism , Malondialdehyde/metabolism , Oxidoreductases/antagonists & inhibitors , Plant Extracts/administration & dosage , Rats , Rats, Wistar
5.
Exp Eye Res ; 88(5): 938-44, 2009 May.
Article in English | MEDLINE | ID: mdl-19150348

ABSTRACT

The present study sought to determine whether acetyl-L-carnitine (ALCAR) prevents selenite cataractogenesis by mechanisms involving lenticular calpain activity, Wistar rat pups were divided into 3 groups of 15 each. Group I (normal) rats received an intraperitoneal (i.p.) injection of normal saline on postpartum day 10; Group II (cataract-untreated) rats received a single subcutaneous (s.c.) injection of sodium selenite (19micromol/kg body weight) on postpartum day 10; Group III (cataract-treated) pups received a single s.c. injection of sodium selenite on postpartum day 10 and intraperitoneal injections of acetyl-L-carnitine (200mg/kg body weight) on postpartum days 9-14. At the end of the study period (postpartum day 16), both eyes of each rat pup were examined by slit-lamp biomicroscopy. There was dense lenticular opacification in all Group II rats, minimal lenticular opacification in 33% of Group III rats, and no lenticular opacification in 67% of Group III and in all Group I rats. Group II lenses exhibited significantly lower mean values of calpain activity and Lp82 (lens-specific calpain) protein expression, decreases in relative transcript level of m-calpain mRNA and significantly higher mean Ca(2+) concentrations than Group I or Group III lenses; the values of these parameters in Group III rat lenses (ALCAR-treated) approximated those in Group I rat lenses. The results suggest that, in addition to its already-described antioxidant potential, ALCAR prevents selenite cataractogenesis by maintaining calpain activity at near normal levels. These findings may stimulate further efforts to develop ALCAR as a novel drug for prevention of cataract.


Subject(s)
Acetylcarnitine/therapeutic use , Calpain/metabolism , Cataract/prevention & control , Lens, Crystalline/enzymology , Animals , Calcium/metabolism , Calpain/genetics , Cataract/chemically induced , Cataract/enzymology , Cataract/pathology , Drug Evaluation, Preclinical/methods , Gene Expression Regulation, Enzymologic/drug effects , Lens, Crystalline/metabolism , RNA, Messenger/genetics , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction/methods , Sodium Selenite
6.
Chem Biol Interact ; 176(2-3): 108-20, 2008 Nov 25.
Article in English | MEDLINE | ID: mdl-18786523

ABSTRACT

The present work is aimed at evaluating the protective effect of the oyster mushroom, Pleurotus ostreatus on carbon tetrachloride (CCl4)-induced toxicity in male Wistar rats. Significantly elevated mean levels (p<0.05) of malondialdehyde (MDA) and lowered mean levels (p<0.01) of reduced glutathione (GSH), vitamins C and E (p<0.05) were observed in kidneys, heart and brain of rats exposed to CCl4, when compared to values in normal rats. Quantitative and qualitative analysis of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (Gpx) and glutathione-S-transferase (GST) revealed lower activities of these antioxidant enzymes in the kidneys, heart and brain of rats exposed to CCl4. When the extract of P. ostreatus was used to treat rats with CCl4-induced toxicity, it lowered the mean level of MDA, elevated the mean levels of GSH and of vitamins C and E and enhanced the mean activities of CAT, SOD, Gpx and GST so that the values of most of these parameters did not differ significantly from those of normal rats. Histopathological studies confirmed the toxic effects of CCl4 on other organs such as kidneys, heart and brain and also tissue protective effect of the extract of P. ostreatus. These results suggest that an extract of P. ostreatus is able to alleviate the oxidative damage caused by CCl4 in the kidneys, heart and brain of Wistar rats.


Subject(s)
Brain/drug effects , Carbon Tetrachloride/toxicity , Heart/drug effects , Kidney/drug effects , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Pleurotus/chemistry , Animals , Ascorbic Acid/analysis , Brain/enzymology , Brain/metabolism , Catalase/metabolism , Enzyme Activation/drug effects , Glutathione/analysis , Glutathione Peroxidase/metabolism , Glutathione Transferase/metabolism , Kidney/enzymology , Kidney/metabolism , Male , Malondialdehyde/analysis , Plant Extracts/chemistry , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Vitamin E/analysis
7.
Fundam Clin Pharmacol ; 22(3): 275-84, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18485145

ABSTRACT

Oxidative stress is believed to contribute to the pathogenesis of hypercholesterolaemic atherosclerosis; hence, various antioxidant compounds are being evaluated for potential anti-atherogenic effects. The present study assessed the efficacy of epigallocatechin gallate (EGCG), an antioxidant component of the plant Camellia sinensis, in improving serum lipid profile and antioxidant parameters in erythrocytes and cardiac tissue in rats fed an atherogenic diet. In male albino Wistar rats fed an atherogenic diet for 30 days, significantly increased serum levels of total cholesterol, triglycerides and lipoprotein cholesterol fractions and cardiac risk ratio were noted, compared with levels in rats fed a normal diet. Intraperitoneal administration of EGCG (100 mg/kg) for 7 or 15 days to the atherogenic diet-fed rats resulted in significantly lower serum levels of total cholesterol, triglycerides, low-density and very low density lipoprotein cholesterol fractions and a significantly higher serum level of high-density lipoprotein cholesterol compared with levels in atherogenic diet-fed, saline-treated rats. Significantly higher mean malondialdehyde levels and significantly lower mean activities of antioxidant enzymes and mean levels of non-enzymatic antioxidants occurred in atherogenic diet-fed rats compared with those fed a normal diet. When atherogenic diet-fed rats received EGCG treatment for 7 or 15 days, significantly lower mean levels of MDA, higher mean levels of non-enzymatic antioxidants and higher mean activities of enzymatic antioxidants occurred, compared with those in saline-treated rats. Thus, EGCG appears to ameliorate disruptions of serum lipid profile and of antioxidant parameters in erythrocyte and cardiac tissue of Wistar rats fed an atherogenic diet; these results may be relevant to treating human atherosclerosis.


Subject(s)
Antioxidants/pharmacology , Catechin/analogs & derivatives , Diet, Atherogenic , Erythrocytes/drug effects , Lipids/blood , Animals , Anticholesteremic Agents/pharmacology , Anticholesteremic Agents/therapeutic use , Antioxidants/therapeutic use , Aorta, Thoracic/drug effects , Aorta, Thoracic/enzymology , Ascorbic Acid/metabolism , Atherosclerosis/drug therapy , Atherosclerosis/etiology , Camellia sinensis/chemistry , Catalase/metabolism , Catechin/pharmacology , Catechin/therapeutic use , Erythrocytes/enzymology , Glutathione Peroxidase/metabolism , Hypercholesterolemia/drug therapy , Hypercholesterolemia/etiology , Injections, Intraperitoneal , Lipid Peroxidation/drug effects , Male , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Vitamin E/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL